Enhancement of carbamazepine dissolution: In vitro and in vivo evaluation

International Journal of Pharmaceutics

Volumn 168, Issue 2, 1998, Pages 209-220

  El Zein, Hind ^a   Riad, Lillian ^a   El Bary, Ahmed Abd ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Bioavailability; Carbamazepine; Complex; Coprecitpitate; Dissolution; Solid dispersion

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBAMAZEPINE; DRUG METABOLITE; MACROGOL DERIVATIVE; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; SUSPENSION; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

EID: 0032526833     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00093-3     Document Type: Article

References (23)

1. Badawy S.I.F., Chen F.F., Ghorab M.M., Adeyeye C.M. Oral bioavailability of danazol from hydroxypropyl-β-cyclodextrin complex in rats. Pharm. Res. 11:1994;S297.
2. Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet. 3:1978;128-143.
3. Biswas M., Akogyeram C.O., Scott K.R., Potti G.K., Gallelli J.F., Habib M.J. Development of carbamazepine:phospholipid solid dispersion formulations. J. Control. Rel. 23:1993;239-245.
4. Choudry S., Nelson K. Improvement of oral bioavailability of carbamazepine by inclusion in 2-hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 85:1992;175-180.
5. Craig D.Q.M. Polyethylene glycols and drug release. Drug Dev. Ind. Pharm. 16:1990;2501-2526.
6. Cullity, B.D., 1990. Elements of X-ray Diffraction, 2nd ed. Addison-Wesley, Reading, MA, pp. 397-420.
7. Eichelbaum M., Tomson T., Tybring G., Bertilsson L. Carbamazepine metabolism in man: induction and pharmacogenetic aspects. Clin. Pharmacokinet. 10:1985;80-90.
8. Graves N.M., Kriel R.L., Jones-Seate C., Cloyd J.C. Relative bioavailability of rectally administered suspension in humans. Epilepsia. 26:1985;429-443.
9. Habib M.J., Azadi M., Akogyeram O.C. Enhancement of dissolution rate of probenicid in phospholipid coprecipitates. Drug. Dev. Ind. Pharm. 18:1992;1117-1125.
10. Habib M.J., Akogyeram C., Ahmadi B. Improved dissolution of indomethacin in coprecipitates with phospholipids. Drug Dev. Ind. Pharm. 19:1993;499-505.
11. Harris, J.M., 1992. Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications. Plenum Press, NY, pp. 1-14.
12. Houston J.B. Drug metabolite kinetics. Pharmacol. Ther. 15:1982;521-552.
13. Kaneniwa N., Yamaguchi T., Watari N., Otsuka M. Hygroscopicity of carbamazepine crystalline powders. Yakugaku Zasshi. 104:1984;184-190.
14. Krahn F.U., Mielck J.B. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm. Acta Helv. 62:1987;247-254.
15. Lowes M.M.J., Caira M.R., Lotter A.P., Van Der Watt J.G. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci. 76:1987;744-752.
16. Oppenheimer L., Capizzi P., Weppelman R.M., Mehta H. Determining the lowest limit of reliable assay measurement. Anal. Chem. 55:1983;638-643.
17. Riad, L.E., 1989. The gastrointestinal absorption and first-pass metabolism of carbamazepine in the rabbit. Ph.D. Thesis, University of Minnesota, Minneapolis, MN, USA.
18. Riad L.E., Sawchuk R.J. Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine. Pharm. Res. 8:1991;1050-1055.
19. Riad L.E., Chan K.K.H., Wagner W.E. Jr., Sawchuk R.J. Simultaneous first- and zero-order absorption of carbamazepine tablets in humans. J. Pharm. Sci. 75:1986;897-900.
20. Sawchuk R.J., Cartier L.L. Simultaneous liquid chromatographic determination of carbamazepine and its epoxide metabolite in plasma. Clin. Chem. 28:1982;2127-2130.
21. Tothfalusi L., Endrenyi L. Without extrapolation, Cmax/AUC is an effective metric in investigations of bioequivalence. Pharm. Res. 12:1995;937-942.
22. Umeda T., Ohnishi N., Yokoyama T., Kuroda K., Kuroda T., Tatsumi E., Matsuda Y. Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state. Yakugaku Zasshi. 104:1984;786-792.
23. Venkataram S., Rogers J.A. Characteristics of drug-phospholipid coprecipitates. I: physical properties and dissolution behavior of griseofulvin-dimyristoyl phosphatidyl choline systems. J. Pharm. Sci. 73:1984;757-761.